InvestorsHub Logo
Followers 44
Posts 3153
Boards Moderated 2
Alias Born 01/18/2016

Re: None

Wednesday, 11/01/2023 8:47:21 AM

Wednesday, November 01, 2023 8:47:21 AM

Post# of 878
Conference call. 1 p3 done, still blinded. If, after un-blinding, results are as expected, AA may be a path to pursue with FDA. Otherwise a 2nd P3 is on the table.
https://bioviepharma.com/wp-content/uploads/2023/11/BioVie-Conference-Call-2023-11-01.pdf

All my postings are verified and approved by my dog.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BIVI News